REMSleep (RMSL) 10-K 16 Apr 24 2023 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2023	Apr. 16, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Financial Statement Error Correction [Flag]	false
Entity Interactive Data Current	Yes
ICFR Auditor Attestation Flag	false
Amendment Flag	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Information [Line Items]
Entity Registrant Name	REMSLEEP HOLDINGS, INC.
Entity Central Index Key	0001412126
Entity File Number	000-53450
Entity Tax Identification Number	47-5386867
Entity Incorporation, State or Country Code	NV
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Public Float			$ 16,771,918
Entity Incorporation, Date of Incorporation	Jun. 06, 2007
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	14175 ICOT Blvd
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Clearwater
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33760
Entity Phone Fax Numbers [Line Items]
City Area Code	813
Local Phone Number	367-3855
Entity Listings [Line Items]
No Trading Symbol Flag	true
Title of 12(g) Security	Common Stock, $0.001 par value
Entity Common Stock, Shares Outstanding		1,461,616,601

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2023
Auditor [Table]
Auditor Name	Fruci & Associates II, PLLC
Auditor Firm ID	5525
Auditor Location	Spokane, Washington

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 719,100	$ 1,841,988
Accounts receivable, net of allowance of $5,590 and $0, respectively	9,025	11,698
Other assets	8,710
Inventory	99,147	1,056,007
Total current assets	835,982	2,909,693
Other asset	10,000	10,000
Right of use asset	177,796	303,227
Property and equipment, net	182,536	137,980
Total Assets	1,206,314	3,360,900
Current Liabilities:
Accounts payable	37,000	54,845
Accrued compensation	60,500	52,000
Operating lease liability – current portion	134,438	93,241
Total current liabilities	231,938	474,136
Long Term Liabilities
Operating lease liability – net of current portion	43,676	178,226
Total Liabilities	275,614	652,362
Commitments and Contingencies
STOCKHOLDERS’ EQUITY (DEFICIT):
Common stock, $0.001 par value, 3,000,000,000 shares authorized, 1,461,616,601 shares issued and outstanding	1,461,615	1,461,615
Discount to common stock	(94,708)	(94,708)
Additional paid in capital	13,749,052	13,751,052
Accumulated Deficit	(14,192,759)	(12,414,921)
Total Stockholders’ Equity (Deficit)	930,700	2,708,538
Total Liabilities and Stockholders’ Equity (Deficit)	1,206,314	3,360,900
Series A Preferred Stock
STOCKHOLDERS’ EQUITY (DEFICIT):
Preferred Stock value	5,000	5,000
Series B Preferred Stock
STOCKHOLDERS’ EQUITY (DEFICIT):
Preferred Stock value	500	500
Series C Preferred Stock
STOCKHOLDERS’ EQUITY (DEFICIT):
Preferred Stock value	2,000
Related Party
Current Liabilities:
Accrued interest – related party		90,119
Loan payable – related party		179,191
Due to a related party		$ 4,740

Balance Sheets (Parentheticals)

Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Net of allowance (in Dollars)	$ 5,590	$ 0
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,461,616,601	1,461,616,601
Common stock, shares outstanding	1,461,616,601	1,461,616,601
Series A Preferred Stock
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	5,000,000	5,000,000
Preferred stock, shares outstanding	5,000,000	5,000,000
Series B Preferred Stock
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	500,000	500,000
Series C Preferred Stock
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	2,000,000	0
Preferred stock, shares outstanding	2,000,000	0

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue	$ 203,718	$ 320,719
Cost of goods sold	960,457	248,426
Gross margin	(756,739)	72,293
Professional fees	116,362	115,135
Development expense	294,819	337,033
Lease expense	136,320	114,702
General and administrative	295,402	492,295
Total operating expenses	1,014,903	1,290,165
Loss from operations	(1,771,642)	(1,217,872)
Other expense:
Interest expense	(7,090)	(237,390)
Gain (loss) on disposal of fixed assets	894	(28,264)
Change in fair value of derivative		(3,048)
Total other expense	(6,196)	(268,702)
Loss before income taxes	(1,777,838)	(1,486,574)
Provision for income taxes
Net Loss	(1,777,838)	(1,486,574)
Deemed dividend		(536,732)
Net Loss to Common Shareholders	$ (1,777,838)	$ (2,023,306)
Net loss per share, basic (in Dollars per share)	$ 0	$ 0
Weighted average common shares outstanding, basic (in Shares)	1,461,616,601	1,461,965,506
Related Party
Compensation expense – related party	$ 172,000	$ 231,000

Statements of Operations (Paren

Statements of Operations (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net loss per share, diluted	$ 0	$ 0
Weighted average common shares outstanding, diluted	1,461,616,601	1,461,965,506

Statement of Stockholders_ Equi

Statement of Stockholders’ Equity (Deficit) - USD ($)	Series A Preferred Stock	Series B Preferred Stock	Series C Preferred Stock	Common Stock	Discount to Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 5,000	$ 500		$ 1,234,006	$ (94,708)	$ 11,865,439	$ (10,391,615)	$ 2,618,622
Balance (in Shares) at Dec. 31, 2021	5,000,000	500,000		1,234,008,735
Common stock issued for conversion of debt				$ 43,481		678,009		721,490
Common stock issued for conversion of debt (in Shares)				43,479,662
Common stock issued for cash				$ 114,000		741,000		855,000
Common stock issued for cash (in Shares)				114,000,000
Warrants converted to common stock				$ 70,128		(70,128)
Warrants converted to common stock (in Shares)				70,128,204
Warrant down round protection						536,732	(536,732)
Net Loss							(1,486,574)	(1,486,574)
Balance at Dec. 31, 2022	$ 5,000	$ 500		$ 1,461,615	(94,708)	13,751,052	(12,414,921)	2,708,538
Balance (in Shares) at Dec. 31, 2022	5,000,000	500,000		1,461,616,601
Shares issued for intangibles – related party			$ 2,000			(2,000)
Shares issued for intangibles – related party (in Shares)			2,000,000
Net Loss							(1,777,838)	(1,777,838)
Balance at Dec. 31, 2023	$ 5,000	$ 500	$ 2,000	$ 1,461,615	$ (94,708)	$ 13,749,052	$ (14,192,759)	$ 930,700
Balance (in Shares) at Dec. 31, 2023	5,000,000	500,000	2,000,000	1,461,616,601

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (1,777,838)	$ (1,486,574)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	102,198	61,079
Inventory impairment	738,113
Change in fair value of derivative		3,048
Discount amortization		206,157
Gain (loss) on disposal of fixed assets	874	28,264
Operating lease expense	32,078	15,732
Changes in Operating Assets and Liabilities:
Accounts receivable	2,673	(11,698)
Prepaids and other assets	(8,710)	(47,491)
Inventory	218,747	(1,056,007)
Accounts payable	(17,845)	39,339
Accrued compensation – related party	8,500	5,000
Accrued interest		(13,521)
Accrued interest – related party	(90,119)	22,614
Net cash used by operating activities	(791,329)	(2,234,058)
Cash Flows from Investing Activities:
Purchase of property and equipment	(147,628)	(122,262)
Net cash used by investing activities	(147,628)	(122,262)
Cash Flows from Financing Activities:
Repayment of loans		(45,000)
Repayment of loans – related party	(183,931)
Cash advance – related party		4,740
Proceeds from sale of common stock		855,000
Net cash (used) provided by financing activities	(183,931)	814,740
Net change in cash	(1,122,888)	(1,541,580)
Cash at beginning of the year	1,841,988	3,383,568
Cash at end of the year	719,100	1,841,988
Supplemental cash flow information:
Interest paid in cash		22,140
Taxes paid
Supplemental non-cash disclosure:
Common stock issued for conversion of note payable principal and accrued interest		427,730
Establish right of use asset		328,803
Series C preferred stock issued for intangibles – related party	$ 2,000

Background

Background	12 Months Ended
	Dec. 31, 2023
Background [Abstract]
BACKGROUND	NOTE 1 - BACKGROUND Business Activity REMSleep Holdings, Inc., (the “Company”) was incorporated in the State of Nevada on June 6, 2007. On January 5, 2015 the name of the Company was changed to REMSleep Holdings, Inc. and the business model was changed to reflect the new direction of the Company; to develop and distribute products to help people affected by sleep apnea. On May 30, 2015 REMSleep LLC was formally merged into REMSleep Holdings, Inc.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Concentrations of Credit Risk We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”). As of December 31, 2023 and 2022, the Company had $469,100 and $1,591,988 of cash above the FDIC’s $250,000 coverage limit, respectively. Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents for the periods ended December 31, 2023 and 2022. Property and Equipment Fixed assets are carried at the lower of cost or net realizable value. All fixed assets with a cost of $2,000 or greater are capitalized. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the assets, which range from three to five years. Leasehold improvements are amortized over the lesser of the remaining term of the lease or the estimated useful life of the asset. Major betterments that extend the useful lives of assets are also capitalized. Normal maintenance and repairs are charged to expense as incurred. When assets are sold or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in operations. Basic and Diluted Earnings Per Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. Diluted amounts are not presented when the effect of the computations are anti-dilutive due to the losses incurred. Accordingly, there is no difference in the amounts presented for basic and diluted loss per share. As of December 31, 2023, the Company had approximately 5,000,000 potentially dilutive shares from Series A preferred stock, 50,000,000 from Series B preferred stock and 600,000,000 from Series C preferred stock. As of December 31, 2022, the Company had approximately 172,500,000 potentially dilutive shares of common stock warrants, 5,000,000 shares from Series A preferred stock and 50,000,000 from Series B preferred stock. Stock-Based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 allows companies to account for nonemployee awards in the same manner as employee awards. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods. Fair Value of Financial Instruments The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximate the fair value of such instruments as the notes bear interest rates that are consistent with current market rates. Revenue Recognition The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps: ● Identification of a contract with a customer; ● Identification of the performance obligations in the contract; ● Determination of the transaction price; ● Allocation of the transaction price to the performance obligations in the contract; and ● Recognition of revenue when or as the performance obligations are satisfied. All orders are received online at which time payment is made. When payment is approved the product is shipped. When the product ships control of the promised goods is transferred to the customers and the revenue is recognized. Warranties The Company is currently selling its ResPlus Auto CPAP Machine (“ResPlus”). The ResPlus is imported by the Company and sold primarily to Durable Medical Equipment companies to patients with sleep apnea. The manufacturer warranties the unit for 2 years parts and labor. During the last twelve months the Company has received back eight units for warranty repair, out of approximately 1,000 units sold. As of December 31, 2023, there is no accrual for warranty expense due to the low cost of replacement to date. If returns are to increase, management will determine if it needs to account for the cost of returns and establish a warranty accrual. Accounts Receivable Revenues that have been recognized but not yet received are recorded as accounts receivable. Losses on receivables will be recognized when it is more likely than not that a receivable will not be collected. An allowance for estimated uncollectible amounts will be recognized to reduce the amount of receivables to its net realizable value when needed. Based on collection experience and periodic reviews of outstanding receivables, for the year ended December 31, 2023, the Company recognized $20,886 of bad debt expense for uncollectable accounts. As of December 31 Inventories Inventories are stated at the lower of cost or net realizable value. Inventory on hand consists of finished goods purchased from third parties. When there is evidence that the inventory’s value is less than original cost, the inventory is reduced to market value. We determine market value on current resale amounts and whether technological obsolescence exists. As of December 31, 2023, the Company determined that the value of its inventory had fallen below cost and required impairment down to market value. As a result we recognized impairment expense of $738,113 for the year ended December 31, 2023. Recently Adopted Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2023
Going Concern [Abstract]
GOING CONCERN	NOTE 3 - GOING CONCERN The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has an accumulated deficit of $14,192,759 at December 31 31 The Company has completed its initial product development and has begun selling its product in Q2 of 2022. In addition, the Company has been in the process of obtaining its 510k for its DeltaWave product. FDA approval is expected by the second quarter of 2024. The Company will continue to finance its operations through debt and/or equity financing as needed.

Property & Equipment

Property & Equipment	12 Months Ended
	Dec. 31, 2023
Property & Equipment [Abstract]
PROPERTY & EQUIPMENT	NOTE 4 - PROPERTY & EQUIPMENT Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets as follows between three and five years. Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income. Assets stated at cost, less accumulated depreciation consisted of the following: December 31, December 31, Furniture/fixtures $ 39,746 $ 39,746 Office equipment 43,780 43,780 Automobile 37,410 29,905 Tooling/Molds 214,454 86,005 Less: accumulated depreciation (152,854 ) (61,456 ) Fixed assets, net $ 182,536 $ 137,980 Depreciation expense Depreciation expense for the years ended December 31, 2023 and 2022 was $102,198 and $61,079, respectively.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 - RELATED PARTY TRANSACTIONS The Company has received support from its Chairman, Russell Bird through a series of loans prior to 2019 for a total loan of $179,191. The loan is unsecured and due on demand. During the three months ended March 31, 2023, the Company repaid $100,000 of the loan. On June 14, 2023, the company repaid $79,191 and $97,209 of principal and interest, respectively, paying the loan back in full. As of December 31, 2023 and 2022, the balance due is $0 $0 The Company executed a new employment agreement with Mr. Wood on April 1, 2022. Per the terms of the agreement Mr. Wood is to be compensated $8,000 per month. As of December 31, 2023 and 2022, there is $14,500 and $2,000 of accrued compensation, respectively, due to Mr. Wood. During the years ended December 31, 2023 and 2022, cash payments of $83,500 and $84,000, respectively, were paid to Mr. Wood. The Company executed a new employment agreement with its Chairman, Russell Bird, on April 1, 2022. Per the terms of the agreement, which is effective for one year, Mr. Bird is to be compensated $8,000 per month. As of December 31, 2023 and 2022, there is $46,000 and $50,000 of accrued compensation, respectively, due to Mr. Bird. During the years ended December 31, 2023 and 2022, cash payments of $44,000 and $76,000, respectively, were paid to Mr. Bird. Effective June 1, 2023, Mr. Bird resigned from all positions with the Company. The Company has entered into an at-will consulting agreement with Jonathan Lane to serve as Chief Technology Officer. During the years ended December 31, 2023 and 2022, the Company made cash payments to Mr. Lane of $36,000 and $66,000, respectively. During the years ended December 31 2023 and 2022, the Company paid $19,000 and $9,500, respectively, to the brother of the CEO for services related to development of the Company’s product. During the years ended December 31, 2023 and 2022, the Company paid $0 On September 6, 2023, the Company entered into an intellectual property assignment agreement (the “IP Purchase Agreement”) with Mr. Wood, pursuant to which the Company has agreed to issue to Mr. Wood a total of 2,000,000 shares of Series C Preferred Stock.

Operating Leases

Operating Leases	12 Months Ended
	Dec. 31, 2023
Operating Leases [Abstract]
OPERATING LEASES	NOTE 6 - OPERATING LEASES The Company entered into a Lease Agreement (the “Lease”) with 14175 Icot Blvd, LLC (the “Lessor”), effective May 1, 2022, relating to approximately 9,677 square feet of property located at 14175 Icot Blvd, Clearwater, FL 33760. The term of the Lease is for thirty-six (36) months commencing May 1, 2022. The monthly base rent, including tax is $8,686.71 for the first twelve (12) months increasing thereafter to $9,034.17 for the next 12 months and to $12,287.63 for the last 12 months. The Company paid $69,494 of advanced rent. The advance rent is to be allocated equally over the first two years of the lease. In February 2016, the FASB issued Accounting Standard Update (“ASU”) 2016-02, Leases Leases Adoption of Accounting Standard Update (“ASU”) 2016-02, Leases Asset Balance Sheet Classification December 31, Operating lease asset Right of use asset $ 177,796 Total lease asset $ 177,796 Liability Operating lease liability – current portion Current operating lease liability $ 134,438 Operating lease liability – noncurrent portion Long-term operating lease liability 43,676 Total lease liability $ 178,114 Lease obligations at December 31 consisted of the following: For the year ended December 31: 2024 $ 134,438 2025 49,151 Total payments $ 183,589 Amount representing interest $ (5,475 ) Lease obligation, net 178,114 Less current portion (134,438 ) Lease obligation – long term $ 43,676 The operating lease expense for the above agreement for the December 31 was $136,320 which consisted of amortization expense of $103,613, $18,928 of prepaid rent and interest expense of $13,779. During the year ended December 31

Common Stock

Common Stock	12 Months Ended
	Dec. 31, 2023
Common Stock [Abstract]
COMMON STOCK	NOTE 7 - COMMON STOCK During Q1 2022, Granite Global Value converted $152,880 of principal and interest into 16,146,666 shares of common stock. During Q1 2022, the Company issued 70,128,204 shares of common stock for the conversion of warrants. During Q1 2022, the Company sold 114,000,000 shares of common stock for total cash proceeds of $855,000. The shares were sold pursuant to its Tier 2 of Regulation A Offering Statement. During Q1 and Q2 2022, Power Up Lending Group LTD converted $274,850 of principal and interest into 27,332,996 shares of common stock.

Preferred Stock

Preferred Stock	12 Months Ended
	Dec. 31, 2023
Preferred Stock [Abstract]
PREFERRED STOCK	NOTE 8 - PREFERRED STOCK The Company is currently authorized to issue 5,000,000 shares of Series A Preferred Stock, par value $0.001 per share with 1:25 voting rights. The Series A Preferred Stock ranks equal to the common stock on liquidation, pays no dividend and is convertible to common stock for one share of common for one share of Series A Preferred Stock. The Company is currently authorized to issue 5,000,000 shares of Series B Preferred Stock, par value $0.001 per share. Each share of Series B Preferred Stock has a 1:100 voting right and is convertible into 100 shares of common stock. No dividends will be paid and in the event of liquidation all shares of Series B will automatically convert into common stock. There are 500,000 shares of Series B Preferred Stock issued and outstanding. The Company is currently authorized to issue 5,000,000 shares of Series C Preferred Stock, par value $0.001 per share. On July 24, 2023, the Company filed an Amended and Restated Certificate of Designations of the Series C Preferred Shares. The Series C Preferred may vote on any action upon which holders of the Company’s common stock may vote, and they shall vote together as one class with voting rights equal to eighty one percent (81%) of all the issued and outstanding shares of common stock of the Company. Each share of Series C Preferred can be converted into 300 shares of the Company’s common stock.

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2023
Income Tax [Abstract]
INCOME TAX	NOTE 9 - INCOME TAX Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has evaluated Staff Accounting Bulletin No. 118 regarding the impact of the decreased tax rates of the Tax Cuts & Jobs Act. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The U.S. federal income tax rate of 21% is being used. The provision for Federal income tax consists of the following December 31: 2023 2022 Federal income tax benefit attributable to: Current Operations $ 373,000 $ 312,000 Less: valuation allowance (373,000 ) (312,000 ) Net provision for Federal income taxes $ - $ - The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows: 2023 2022 Deferred tax asset attributable to: Net operating loss carryover $ 2,980,000 $ 2,494,000 Less: valuation allowance (2,980,000 ) (2,494,000 ) Net deferred tax asset $ - $ - At December 31, 2023, the Company had net operating loss carry forwards of approximately $2,980,000 that may be offset against future taxable income. NOLs from tax years up to 2017 can be carried forward twenty years. Under the CARES Act, the Company carry forward NOLs indefinitely for NOLs generated in a tax year beginning after 2017, that remain after they are carried back to tax years in the five-year carryback period. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for Federal Income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for years before 2016.

Warrants

Warrants	12 Months Ended
	Dec. 31, 2023
Warrants [Abstract]
WARRANTS	NOTE 10 - WARRANTS Number of Weighted Weighted Aggregate Exercisable at December 31, 2021 226,500,000 $ 0.0013 3.78 $ — Granted (1) 6,000,000 $ — — $ — Expired — $ — — $ — Exercised (60,000,000 ) $ — — $ — Exercisable at December 31, 2022 172,500,000 $ 0.0104 3.14 $ 1,665,500 Granted — $ — — $ — Expired — $ — — $ — Cancelled (172,500,000 ) $ — — $ — Exercisable at December 31, 2023 (2) — $ — — $ — (1) The outstanding warrants include an anti-dilutive clause requiring adjustment to the exercise price for any reason outlined in the agreement. The number of warrant shares is increased so that the aggregated exercise price is equal to the original exercise price. The fair value of any additional warrants is recognized as a deemed dividend. (2) The Company received a Settlement and Mutual Release Agreement, effective July 6, 2023, from Granite Global Value Investments Ltd, that cancels all remaining warrants with the Company.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 11 - COMMITMENTS AND CONTINGENCIES The Company has been in the process of obtaining its 510k for DeltaWave. This requires a myriad of tests to prove to the FDA that the device is safe and effective. The company has diligently carried out these tests through independent testing labs. There have been no issues aside from a negative result on a cytotoxicity test due to incorrect procedures performed by a third-party lab. This roadblock has required the company to perform a retest. The company has failed the retest due to what is believed to be a faulty analysis by the testing company. The company believes they can narrow down the exact part of the device that is failing the test and quickly resolve this matter. The company has engaged a new testing company appropriately suited for the Company’s specific testing requirements. Testing is expected to be completed in the second quarter of 2024. The 510K will be submitted immediately after testing is completed.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 - SUBSEQUENT EVENTS In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued and has determined that it has the following material subsequent event to disclose in these financial statements. On January 10, 2024, the Company issued a 10% Convertible Promissory Note (the “Note”) for $143,000 to 1800 Diagonal Lending LLC. The Note includes an OID of $13,000 and matures on January 10, 2025. The Note is convertible into shares of common stock, beginning 180 days after the issue date, at a 25% discount to the average of the three lowest trades during the ten days prior to the date of conversion.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (1,777,838)	$ (1,486,574)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Concentrations of Credit Risk	Concentrations of Credit Risk We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”). As of December 31, 2023 and 2022, the Company had $469,100 and $1,591,988 of cash above the FDIC’s $250,000 coverage limit, respectively.
Cash Equivalents	Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents for the periods ended December 31, 2023 and 2022.
Property and Equipment	Property and Equipment Fixed assets are carried at the lower of cost or net realizable value. All fixed assets with a cost of $2,000 or greater are capitalized. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the assets, which range from three to five years. Leasehold improvements are amortized over the lesser of the remaining term of the lease or the estimated useful life of the asset. Major betterments that extend the useful lives of assets are also capitalized. Normal maintenance and repairs are charged to expense as incurred. When assets are sold or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in operations.
Basic and Diluted Earnings Per Share	Basic and Diluted Earnings Per Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. Diluted amounts are not presented when the effect of the computations are anti-dilutive due to the losses incurred. Accordingly, there is no difference in the amounts presented for basic and diluted loss per share. As of December 31, 2023, the Company had approximately 5,000,000 potentially dilutive shares from Series A preferred stock, 50,000,000 from Series B preferred stock and 600,000,000 from Series C preferred stock. As of December 31, 2022, the Company had approximately 172,500,000 potentially dilutive shares of common stock warrants, 5,000,000 shares from Series A preferred stock and 50,000,000 from Series B preferred stock.
Stock-Based Compensation	Stock-Based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 allows companies to account for nonemployee awards in the same manner as employee awards. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximate the fair value of such instruments as the notes bear interest rates that are consistent with current market rates.
Revenue Recognition	Revenue Recognition The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps: ● Identification of a contract with a customer; ● Identification of the performance obligations in the contract; ● Determination of the transaction price; ● Allocation of the transaction price to the performance obligations in the contract; and ● Recognition of revenue when or as the performance obligations are satisfied. All orders are received online at which time payment is made. When payment is approved the product is shipped. When the product ships control of the promised goods is transferred to the customers and the revenue is recognized.
Warranties	Warranties The Company is currently selling its ResPlus Auto CPAP Machine (“ResPlus”). The ResPlus is imported by the Company and sold primarily to Durable Medical Equipment companies to patients with sleep apnea. The manufacturer warranties the unit for 2 years parts and labor. During the last twelve months the Company has received back eight units for warranty repair, out of approximately 1,000 units sold. As of December 31, 2023, there is no accrual for warranty expense due to the low cost of replacement to date. If returns are to increase, management will determine if it needs to account for the cost of returns and establish a warranty accrual.
Accounts Receivable	Accounts Receivable Revenues that have been recognized but not yet received are recorded as accounts receivable. Losses on receivables will be recognized when it is more likely than not that a receivable will not be collected. An allowance for estimated uncollectible amounts will be recognized to reduce the amount of receivables to its net realizable value when needed. Based on collection experience and periodic reviews of outstanding receivables, for the year ended December 31, 2023, the Company recognized $20,886 of bad debt expense for uncollectable accounts. As of December 31
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Inventory on hand consists of finished goods purchased from third parties. When there is evidence that the inventory’s value is less than original cost, the inventory is reduced to market value. We determine market value on current resale amounts and whether technological obsolescence exists. As of December 31, 2023, the Company determined that the value of its inventory had fallen below cost and required impairment down to market value. As a result we recognized impairment expense of $738,113 for the year ended December 31, 2023.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Property & Equipment (Tables)

Property & Equipment (Tables)	12 Months Ended
	Dec. 31, 2023
Property & Equipment [Abstract]
Schedule of Assets Stated at Cost, Less Accumulated Depreciation	Assets stated at cost, less accumulated depreciation consisted of the following: December 31, December 31, Furniture/fixtures $ 39,746 $ 39,746 Office equipment 43,780 43,780 Automobile 37,410 29,905 Tooling/Molds 214,454 86,005 Less: accumulated depreciation (152,854 ) (61,456 ) Fixed assets, net $ 182,536 $ 137,980

Operating Leases (Tables)

Operating Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Operating Leases [Abstract]
Schedule of Right-of-Use (“ROU”) Assets and Operating Lease Liabilities	Adoption of Accounting Standard Update (“ASU”) 2016-02, Leases Asset Balance Sheet Classification December 31, Operating lease asset Right of use asset $ 177,796 Total lease asset $ 177,796 Liability Operating lease liability – current portion Current operating lease liability $ 134,438 Operating lease liability – noncurrent portion Long-term operating lease liability 43,676 Total lease liability $ 178,114
Schedule of Lease Obligations	Lease obligations at December 31 consisted of the following: For the year ended December 31: 2024 $ 134,438 2025 49,151 Total payments $ 183,589 Amount representing interest $ (5,475 ) Lease obligation, net 178,114 Less current portion (134,438 ) Lease obligation – long term $ 43,676

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax [Abstract]
Schedule of Provision for Federal Income Tax	The provision for Federal income tax consists of the following December 31: 2023 2022 Federal income tax benefit attributable to: Current Operations $ 373,000 $ 312,000 Less: valuation allowance (373,000 ) (312,000 ) Net provision for Federal income taxes $ - $ -
Schedule of Net Deferred Tax	The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows: 2023 2022 Deferred tax asset attributable to: Net operating loss carryover $ 2,980,000 $ 2,494,000 Less: valuation allowance (2,980,000 ) (2,494,000 ) Net deferred tax asset $ - $ -

Warrants (Tables)

Warrants (Tables)	12 Months Ended
	Dec. 31, 2023
Warrants [Abstract]
Schedule of Outstanding Stock Warrants	Number of Weighted Weighted Aggregate Exercisable at December 31, 2021 226,500,000 $ 0.0013 3.78 $ — Granted (1) 6,000,000 $ — — $ — Expired — $ — — $ — Exercised (60,000,000 ) $ — — $ — Exercisable at December 31, 2022 172,500,000 $ 0.0104 3.14 $ 1,665,500 Granted — $ — — $ — Expired — $ — — $ — Cancelled (172,500,000 ) $ — — $ — Exercisable at December 31, 2023 (2) — $ — — $ — (1) The outstanding warrants include an anti-dilutive clause requiring adjustment to the exercise price for any reason outlined in the agreement. The number of warrant shares is increased so that the aggregated exercise price is equal to the original exercise price. The fair value of any additional warrants is recognized as a deemed dividend. (2) The Company received a Settlement and Mutual Release Agreement, effective July 6, 2023, from Granite Global Value Investments Ltd, that cancels all remaining warrants with the Company.

Background (Details)

Background (Details)	12 Months Ended
	Dec. 31, 2023
Background [Abstract]
Incorporation date	Jun. 06, 2007

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]
Cash	$ 469,100	$ 1,591,988
Federal depository insurance coverage limit	250,000
Fixed assets cost	$ 2,000
Dilutive shares		172,500,000
Warrants term	2 years
Total number of units sold	1,000
Bad debt expense for uncollectable accounts	$ 20,886
Allowance for doubtful account		$ 5,590
Impairment expense of inventories	$ 738,113
Minimum [Member]
Summary of Significant Accounting Policies [Line Items]
Property and equipment estimated useful lives	3 years
Maximum [Member]
Summary of Significant Accounting Policies [Line Items]
Property and equipment estimated useful lives	5 years
Series A Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Dilutive shares	5,000,000
Series A Preferred Stock [Member] | Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Dilutive shares		5,000,000
Series B Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Dilutive shares	50,000,000
Series B Preferred Stock [Member] | Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Dilutive shares		50,000,000
Series C Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Dilutive shares	600,000,000

Going Concern (Details)

Going Concern (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Going Concern [Abstract]
Accumulated deficit	$ (14,192,759)	$ (12,414,921)
Net loss	(1,777,838)	$ (1,486,574)
Net cash used in operating activities	$ 791,309

Property & Equipment (Details)

Property & Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Property & Equipment [Line Items]
Depreciation expense	$ 102,198	$ 61,079
Minimum [Member]
Property & Equipment [Line Items]
Property, plant and equipment, useful llife	3 years
Maximum [Member]
Property & Equipment [Line Items]
Property, plant and equipment, useful llife	5 years

Property & Equipment (Details)

Property & Equipment (Details) - Schedule of Assets Stated at Cost, Less Accumulated Depreciation - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (152,854)	$ (61,456)
Fixed assets, net	182,536	137,980
Furniture/fixtures [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	39,746	39,746
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	43,780	43,780
Automobile [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	37,410	29,905
Tooling/Molds [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 214,454	$ 86,005

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)			3 Months Ended	12 Months Ended
	Jun. 14, 2023	Jan. 01, 2019	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	Sep. 06, 2023
Related Party Transactions [Line Items]
Repaid loan			$ 100,000
Repaid amount	$ 79,191				$ 45,000
Principal and interest	$ 97,209
Balance due accrues interest		12.50%
Agreement term				1 year
Technology Service [Member]
Related Party Transactions [Line Items]
Company paid				$ 19,000	9,500
Website design services					$ 1,000
Series C Preferred Stock [Member]
Related Party Transactions [Line Items]
Preferred stock issued (in Shares)				2,000,000	0
Mr. Wood [Member]
Related Party Transactions [Line Items]
Compensated per month				$ 8,000
Accrued compensation				14,500	$ 2,000
Cash payments				83,500	84,000
Mr. Wood [Member] | Series C Preferred Stock [Member]
Related Party Transactions [Line Items]
Preferred stock issued (in Shares)						2,000,000
Mr. Bird [Member]
Related Party Transactions [Line Items]
Compensated per month				8,000
Accrued compensation				46,000	50,000
Cash payments				44,000	76,000
Mr. Lane [Member]
Related Party Transactions [Line Items]
Cash payments				36,000	66,000
Russell Bird [Member]
Related Party Transactions [Line Items]
Loans payable				179,191
Related Party [Member]
Related Party Transactions [Line Items]
Loans payable					179,191
Total accrued interest					$ 90,119

Operating Leases (Details)

Operating Leases (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	May 01, 2022
Operating Leases [Line Items]
Description of lease agreement	The Company entered into a Lease Agreement (the “Lease”) with 14175 Icot Blvd, LLC (the “Lessor”), effective May 1, 2022, relating to approximately 9,677 square feet of property located at 14175 Icot Blvd, Clearwater, FL 33760.
Monthly base rent first twelve months	$ 8,686.71
Monthly base rent next twelve months	9,034.17
Monthly base rent last twelve months	12,287.63
Advanced rent	69,494
Operating lease liabilities	178,114
Operating lease expense	136,320	$ 114,702
Amortization expense	103,613
Prepaid rent	18,928
Interest expense	13,779
Rent expense	$ 8,675
ROU [Member]
Operating Leases [Line Items]
Operating lease liabilities			$ 328,803

Schedule of Right-of-Use (_ROU_

Schedule of Right-of-Use (“ROU”) Assets and Operating Lease Liabilities (Details) - Schedule of Right-of-Use (“ROU”) Assets and Operating Lease Liabilities - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Disclosure Text Block Abstract
Right of use asset	Total lease asset	Total lease asset
Operating lease asset	$ 177,796
Total lease asset	$ 177,796	$ 303,227
Current operating lease liability	Operating lease liability – current portion	Operating lease liability – current portion
Operating lease liability – current portion	$ 134,438	$ 93,241
Long-term operating lease liability	Operating lease liability – noncurrent portion	Operating lease liability – noncurrent portion
Operating lease liability – noncurrent portion	$ 43,676	$ 178,226
Total lease liability	$ 178,114

Operating Leases (Details) - Sc

Operating Leases (Details) - Schedule of Lease Obligations - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Schedule of Lease Obligations [Abstract]
2024	$ 134,438
2025	49,151
Total payments	183,589
Amount representing interest	(5,475)
Lease obligation, net	178,114
Less current portion	(134,438)	$ (93,241)
Lease obligation – long term	$ 43,676	$ 178,226

Common Stock (Details)

Common Stock (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Common Stock [Line Items]
Converted of principal and interest (in Dollars)
Shares of common stock	114,000,000
Total cash proceeds (in Dollars)	$ 855,000			$ 855,000
Warrants [Member]
Common Stock [Line Items]
Converted shares	70,128,204
Granite Global Value [Member]
Common Stock [Line Items]
Converted shares	16,146,666
Granite Global Value [Member]
Common Stock [Line Items]
Converted of principal and interest (in Dollars)	$ 152,880
Power Up Lending Group LTD [Member]
Common Stock [Line Items]
Converted of principal and interest (in Dollars)	$ 274,850	$ 274,850
Converted shares	27,332,996	27,332,996

Preferred Stock (Details)

Preferred Stock (Details) - $ / shares		12 Months Ended
	Jul. 24, 2023	Dec. 31, 2023	Dec. 31, 2022
Preferred Stock [Line Items]
Converted shares of common stock		1
Percentage of common stock issued and outstanding	81%
Series A Preferred Stock [Member]
Preferred Stock [Line Items]
Preferred stock, shares authorized		5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)		$ 0.001	$ 0.001
Voting rights, description		1:25 voting rights
Converted shares of common stock		1
Preferred stock, shares issued		5,000,000	5,000,000
Preferred stock, shares outstanding		5,000,000	5,000,000
Series B Preferred Stock [Member]
Preferred Stock [Line Items]
Preferred stock, shares authorized		5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)		$ 0.001	$ 0.001
Voting rights, description		Each share of Series B Preferred Stock has a 1:100 voting right and is convertible into 100 shares of common stock
Preferred stock, shares issued		500,000	500,000
Series B Preferred Stock [Member] | Common Stock [Member]
Preferred Stock [Line Items]
Preferred stock, shares outstanding		500,000
Series C Preferred Stock [Member]
Preferred Stock [Line Items]
Preferred stock, shares authorized		5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)		$ 0.001	$ 0.001
Voting rights, description	one
Converted shares of common stock	300
Preferred stock, shares issued		2,000,000	0
Preferred stock, shares outstanding		2,000,000	0

Income Tax (Details)

Income Tax (Details)	12 Months Ended
	Dec. 31, 2023 USD ($)
Income Tax [Abstract]
U.S. federal income tax rate	21%
Cumulative tax rate	21%
Net operating loss carry forwards (in Dollars)	$ 2,980,000

Income Tax (Details) - Schedule

Income Tax (Details) - Schedule of Provision for Federal Income Tax - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Federal income tax benefit attributable to:
Current Operations	$ 373,000	$ 312,000
Less: valuation allowance	(373,000)	(312,000)
Net provision for Federal income taxes

Income Tax (Details) - Schedu_2

Income Tax (Details) - Schedule of Net Deferred Tax - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred tax asset attributable to:
Net operating loss carryover	$ 2,980,000	$ 2,494,000
Less: valuation allowance	(2,980,000)	(2,494,000)
Net deferred tax asset

Warrants (Details) - Schedule o

Warrants (Details) - Schedule of Outstanding Stock Warrants - USD ($)		12 Months Ended
	Dec. 31, 2021	Dec. 31, 2023		Dec. 31, 2022
Schedule of Outstanding Stock Warrants [Abstract]
Number of Warrants, Granted				6,000,000	[1]
Weighted Average Exercise Price, Granted					[1]
Aggregate Intrinsic Value, Granted					[1]
Number of Warrants, Expired
Weighted Average Exercise Price, Expired
Aggregate Intrinsic Value, Expired
Number of Warrants, Cancelled		(172,500,000)
Weighted Average Exercise Price, Cancelled
Aggregate Intrinsic Value, Cancelled
Number of Warrants, Exercised				(60,000,000)
Weighted Average Exercise Price, Exercised
Aggregate Intrinsic Value, Exercised
Number of Warrants, Exercisable at Ending	226,500,000		[2]	172,500,000
Weighted Average Exercise Price, Exercisable at Ending	$ 0.0013		[2]	$ 0.0104
Weighted Average Remaining Contract Term, Exercisable at Ending	3 years 9 months 10 days			3 years 1 month 20 days
Aggregate Intrinsic Value, Exercisable at Ending			[2]	$ 1,665,500
[1] The outstanding warrants include an anti-dilutive clause requiring adjustment to the exercise price for any reason outlined in the agreement. The number of warrant shares is increased so that the aggregated exercise price is equal to the original exercise price. The fair value of any additional warrants is recognized as a deemed dividend. The Company received a Settlement and Mutual Release Agreement, effective July 6, 2023, from Granite Global Value Investments Ltd, that cancels all remaining warrants with the Company.

Subsequent Events (Details)

Subsequent Events (Details)	Jan. 10, 2024 USD ($)
Subsequent Events (Details) [Line Items]
Percentage of convertible promissory note	10%
Diagonal Lending LLC [Member]
Subsequent Events (Details) [Line Items]
Issuance of convertible promissory debt	$ 143,000
Debt Instrument, Face Amount	$ 13,000
Debt Instrument, Interest Rate, Effective Percentage	25%
Matures date	Jan. 10, 2025